3/18
09:00 am
rhhby
Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation
Low
Report
Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation
3/18
07:14 am
rhhby
R1 Therapeutics raises $77.5m to progress AP306 for hyperphosphatemia [Yahoo! Finance]
Medium
Report
R1 Therapeutics raises $77.5m to progress AP306 for hyperphosphatemia [Yahoo! Finance]
3/17
02:50 am
rhhby
Yahoo Finance [Yahoo! Finance]
Low
Report
Yahoo Finance [Yahoo! Finance]
3/16
04:46 pm
rhhby
Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions [Yahoo! Finance]
Low
Report
Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions [Yahoo! Finance]
3/16
10:29 am
rhhby
Making space for everyday life with spinal muscular atrophy [USA TODAY]
Low
Report
Making space for everyday life with spinal muscular atrophy [USA TODAY]
3/16
02:00 am
rhhby
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
Low
Report
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
3/16
02:00 am
rhhby
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
Low
Report
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
3/13
11:55 am
rhhby
Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics [Yahoo! Finance]
Low
Report
Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics [Yahoo! Finance]
3/12
12:13 pm
rhhby
Foundation Medicine Launches Whole Genome Sequencing Germline Test for Research Use to Accelerate Biopharmaceutical Research and Therapy Development Beyond Oncology [Yahoo! Finance]
Low
Report
Foundation Medicine Launches Whole Genome Sequencing Germline Test for Research Use to Accelerate Biopharmaceutical Research and Therapy Development Beyond Oncology [Yahoo! Finance]
3/12
09:37 am
rhhby
FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer [Yahoo! Finance]
Low
Report
FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer [Yahoo! Finance]
3/11
11:47 am
rhhby
Roche Falters In A Key Breast Cancer Readout [Seeking Alpha]
Low
Report
Roche Falters In A Key Breast Cancer Readout [Seeking Alpha]
3/10
06:42 pm
rhhby
Roche's Breast Cancer Drug Falls Short In Phase 3 Study [Yahoo! Finance]
Low
Report
Roche's Breast Cancer Drug Falls Short In Phase 3 Study [Yahoo! Finance]
3/10
07:28 am
rhhby
Foundation Medicine Announces Expanded Participation in National Cancer Institute's ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker Test, FoundationOne®Liquid CDx [Yahoo! Finance]
Low
Report
Foundation Medicine Announces Expanded Participation in National Cancer Institute's ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker Test, FoundationOne®Liquid CDx [Yahoo! Finance]
3/9
09:22 am
rhhby
Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study [Yahoo! Finance]
Medium
Report
Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study [Yahoo! Finance]
3/9
05:12 am
rhhby
Roche shares drop as oral breast cancer drug fails in trial [Yahoo! Finance]
Low
Report
Roche shares drop as oral breast cancer drug fails in trial [Yahoo! Finance]
3/9
02:16 am
rhhby
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase III persevERA study in ER-positive advanced breast cancer [Yahoo! Finance]
Low
Report
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase III persevERA study in ER-positive advanced breast cancer [Yahoo! Finance]
3/9
02:10 am
rhhby
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
Low
Report
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
3/7
07:53 pm
rhhby
Roche Obesity Trial Success Sparks Fresh Look At Valuation And Pipeline [Yahoo! Finance]
Low
Report
Roche Obesity Trial Success Sparks Fresh Look At Valuation And Pipeline [Yahoo! Finance]
3/7
05:32 am
rhhby
Roche chairman still expects diagnostics hit from US tariffs [Yahoo! Finance Canada]
Low
Report
Roche chairman still expects diagnostics hit from US tariffs [Yahoo! Finance Canada]
3/7
05:30 am
rhhby
Roche chairman still expects diagnostics hit from US tariffs [Yahoo! Finance]
Low
Report
Roche chairman still expects diagnostics hit from US tariffs [Yahoo! Finance]
3/6
01:34 pm
rhhby
Roche and Zealand's Phase II obesity trial divides analyst opinion [Yahoo! Finance]
Low
Report
Roche and Zealand's Phase II obesity trial divides analyst opinion [Yahoo! Finance]
3/6
08:58 am
rhhby
New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech's Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus [Yahoo! Finance]
Low
Report
New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech's Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus [Yahoo! Finance]
3/6
08:45 am
rhhby
New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech’s Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus
Low
Report
New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech’s Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus
3/5
04:35 pm
rhhby
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/5
01:55 pm
rhhby
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity [Yahoo! Finance]
Low
Report
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity [Yahoo! Finance]